股骨脆性骨折后骨骼肌质量显著丢失
这项多中心前瞻性观察研究纳入90例接受手术固定的孤立性股骨脆性骨折老年患者,发现伤后6周骨骼肌质量平均丢失2.4 kg(9%),至6个月仍有1.8 kg持续丢失未恢复,营养正常者反而比营养不良者丢失更多肌肉,肌肉质量每减少1 kg与PROMIS躯体功能评分降低8分相关。
要点
- 伤后6周骨骼肌质量平均丢失2.4 kg(9%),至6个月仍有1.8 kg持续丢失。
- 营养正常者伤后6周肌肉丢失比营养不良者多1.3 kg。
- 肌肉质量每减少1 kg与PROMIS躯体功能评分降低8分相关。
核心结论
- 老年股骨脆性骨折患者发生显著的骨骼肌质量与躯体功能丢失。
- 基线营养充足的参与者实际上比营养不良者丢失更多肌肉,作者认为未来预防肌肉丢失的干预研究应关注老年人群而不论营养状态。
研究设计与样本
- 多中心、前瞻性观察研究,纳入90例接受手术固定的孤立性股骨脆性骨折的65岁及以上成人,平均年龄77.6±9.0岁,女性占74%。
- 入院72小时内采用多频生物电阻抗分析评估骨骼肌质量,并在6周、3个月和6个月重复评估。
- 肌少症采用性别特异的四肢骨骼肌质量指数切点定义;采用微型营养评估在受伤时测量营养状态;采用PROMIS躯体功能域测量躯体功能。
- 采用线性混合模型评估骨骼肌质量和PROMIS躯体功能评分随时间的变化,以及骨骼肌质量变化的相关因素。
主要发现
- 受伤时30例(33%)存在肌少症,44例(49%)有营养不良风险或营养不良。
- 年龄较大与较低的骨骼肌质量相关(年龄≥75岁 vs <75岁:最小二乘均值差 -3.3±1.6 kg;p = 0.042)。
- 从受伤时至6周,参与者平均丢失2.4 kg(9%)骨骼肌质量(95%CI = ‒3.0至‒1.8 kg;p < 0.001)。
- 从基线至6个月,仍存在1.8 kg的持续丢失(95%CI = ‒2.5至‒1.1 kg;p < 0.001)。
- 营养正常者从基线至伤后6周骨骼肌质量丢失比营养不良者多1.3 kg(标准误0.6 kg;p = 0.036);骨骼肌质量每减少1 kg与PROMIS躯体功能评分降低8分相关(模型参数估计0.12,标准误0.04;p = 0.002)。
关键数值与推荐
- 肌少症定义采用性别特异的四肢骨骼肌质量指数切点。
- 营养不良采用微型营养评估测量。
- 躯体功能采用PROMIS躯体功能域测量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 证据等级为预后Level II,原文未报告其他局限性。
- 作者指出未来预防肌肉丢失的干预研究应关注老年人群而不论营养状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Femoral fragility fractures in older adults can result in devastating loss of physical function and independence. Skeletal muscle atrophy likely contributes to disability. The purpose of this study was to characterize the change in skeletal muscle mass, investigate the relationship with malnutrition and physical function, and identify risk factors for skeletal muscle loss. METHODS: Adults ≥65 years of age who were treated with operative fixation of an isolated femoral fragility fracture were enrolled in this multicenter, prospective observational study. Skeletal muscle mass was assessed within 72 hours of admission using multifrequency bioelectrical impedance analysis, which was repeated at 6 weeks, 3 months, and 6 months. Sarcopenia was defined by sex-specific cutoffs for the appendicular skeletal muscle mass index. The Mini Nutritional Assessment was used to measure nutritional status at the time of injury. Physical function was measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function domain. Linear mixed models were used to evaluate changes in skeletal muscle mass and PROMIS Physical Function scores over time and to evaluate factors associated with skeletal muscle mass changes. RESULTS: Ninety participants (74% female) with a mean age of 77.6 ± 9.0 years were enrolled. At the time of injury, 30 (33%) were sarcopenic and 44 (49%) were at risk for malnutrition or had malnutrition. Older age was associated with lower skeletal muscle mass (age of ≥75 versus <75 years: least squares mean [and standard error], -3.3 ± 1.6 kg; p = 0.042). From the time of injury to 6 weeks, participants lost an average of 2.4 kg (9%) of skeletal muscle mass (95% confidence interval [CI] = ‒3.0 to ‒1.8 kg; p < 0.001). This early loss did not recover by 6 months (1.8 kg persistent loss compared with baseline [95% CI = ‒2.5 to ‒1.1 kg]; p < 0.001). Participants with normal nutritional status lost more skeletal muscle mass from baseline to 6 weeks after injury compared with those with malnutrition (1.3 kg more loss [standard error, 0.6 kg]; p = 0.036). A 1-kg decrease in skeletal muscle mass was associated with an 8-point decrease in the PROMIS Physical Function (model parameter estimate, 0.12 [standard error, 0.04]; p = 0.002). CONCLUSIONS: We found that older adults with femoral fragility fractures lost substantial skeletal muscle mass and physical function. Participants with adequate baseline nutrition actually lost more muscle mass than those who were malnourished, indicating that future investigations of interventions to prevent muscle loss should focus on older adults regardless of nutritional status. LEVEL OF EVIDENCE: Prognostic Level II . See Instructions for Authors for a complete description of levels of evidence.
引用
- Willey MC, Owen EC, Miller A, et al. Substantial Loss of Skeletal Muscle Mass Occurs After Femoral Fragility Fracture. J Bone Joint Surg Am. 2023. PMID: 37738373. doi:10.2106/JBJS.23.00353
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。